Virbac (Virbac) Cash Flow from Others

: $-9 Mil (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

Virbac's cash flow from others for the six months ended in Jun. 2023 was $-3 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Jun. 2023 was $-9 Mil.

Virbac Cash Flow from Others Historical Data

The historical data trend for Virbac's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash Flow from Others

13.60

14.13

-69.80

16.46

-11.49

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Cash Flow from Others																15.00	2.39	-5.14	-6.35	-2.96

Virbac Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-9 Mil.

Virbac Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Virbac's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac (Virbac) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Cash Flow from Others

Comparable Companies

Traded in Other Exchanges

0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.